2023Unpublished venueOpen access

Supplementary Figure 5 from Monocytes and Granulocytes Reduce CD38 Expression Levels on Myeloma Cells in Patients Treated with Daratumumab

Jakub Krejcik, Kris A. Frerichs, Inger S. Nijhof, Berris van Kessel, Jeroen F. van Velzen, Andries C. Bloem, Marloes E.C. Broekmans, Sonja Zweegman, Johan van Meerloo, René J.P. Musters, Pino J. Poddighe, Richard W.J. Groen, Christopher Chiu, Torben Plesner, Henk M. Lokhorst, A. Kate Sasser, Tuna Mutis, Niels W.C.J. van de Donk

Open full text 0 citations

Abstract

Monocytes take up AF488-labeled daratumumab-CD38 complexes from PKH-26-stained UM9 cells.

About this research paper

What this paper is about

Monocytes take up AF488-labeled daratumumab-CD38 complexes from PKH-26-stained UM9 cells.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Monocytes take up AF488-labeled daratumumab-CD38 complexes from PKH-26-stained UM9 cells.

Key concepts: Daratumumab, CD38, Monocyte, Multiple myeloma, Immunology, Cancer research, Medicine, Molecular biology

Related papers

Back to paper searchBrowse research topicsOriginal source
Supplementary Figure 5 from Monocytes and Granulocytes Reduce CD38 Expression Levels on Myeloma Cells in Patients Treated with Daratumumab — Research Paper | ScholarLens